ClinicalTrials.gg
RecruitingNCT06375447Updated Dec 10, 2024

Intelligent Diagnosis and Treatment Model for Insomnia Disorder

An observational study in Insomnia, sponsored by Xuanwu Hospital, Beijing. Recruiting at 5 sites in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-12-10.

Sponsored by Xuanwu Hospital, Beijing · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Dec 2022; still recruiting 3 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
16,000
Ages
18 Years to 75 Years
Sex
All
01

Study summary

To establish a multicenter, multi-dimensional cohort on insomnia disorder and to develop an intelligent model for the diagnosis and treatment of insomnia disorder.

Read the detailed description

The study endeavors to establish a multicenter cohort comprising 16,000 individuals diagnosed with insomnia disorder, with a subsequent 2-year follow-up. Objectives encompass elucidating the natural development of insomnia disorder within diverse populations, identifying associated factors, and evaluating the short-term and long-term impacts on physiological, psychological, and social functions in insomnia disorder. Additionally, the research aims to devise early screening methodologies, precise assessments, and innovative disease classifications utilizing real-time assessment technology within the insomnia disorder cohort. Furthermore, the investigation seeks to ascertain graded diagnoses, treatment modalities, and prognostic indicators based on advanced multi-dimensional real-time assessment technology applied to a substantial insomnia disorder cohort. Finally, the study aims to refine remote interactive diagnostic and treatment modalities tailored to diverse age groups, culminating in developing a systematic graded diagnostic and treatment framework for insomnia disorder.

02

Conditions studied

  • Insomnia

Keywords

  • Insomnia
  • Intelligence Model
  • Prediction
  • Differential diagnosis and treatment
  • System
03

In context

Sleep Initiation and Maintenance Disorders

1,925 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 612 are open to participants now.

This study's planned enrollment of 16,000 is above the median of 134 across 202 observational studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Xuanwu Hospital, Beijing is the lead sponsor of 357 studies on the registry; 226 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with a complaint about insomnia.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. A complaint of insomnia;
  2. Age between 18 and 75;
  3. Able to fill out the scale on their own;
  4. Agree to sign the informed consent to participate in the study and cooperate in completing the follow-up visit.

Exclusion criteria

Exclusion Criteria:

1.A current or history of comorbid Axis I psychiatric disorders.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
16,000 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Patients with insomnia

    Patients with a complaint about insomnia.

    Other: Routine clinical treatment

Interventions

  • OtherRoutine clinical treatment

    Routine clinical treatment is based on the latest international guidelines for insomnia.

06

What researchers measure

Primary outcomes

  1. The change of Pittsburgh Sleep Quality Index (PSQI) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    The PSQI consists of 7 factors ranging from 0 to 3 points, and the total score ranges from 0 to 21 with higher scores indicating poorer quality.

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

Secondary outcomes

  1. The change of Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    The DBAS assessing sleep related cognitions in 16 item rated on a 10-point Likert scale, and the total score ranges from 0 to 160 with higher scores indicating more intensive disfunctional beliefs.

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  2. The change of Epworth Sleepiness Scale (ESS) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    The ESS assessing daytime sleepiness consists of 8-items on a 4-point Likert scale, and the total score ranges from 0 to 24 with higher scores indicating more sleepiness.

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  3. The change of sleep onset latency from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    Sleep onset latency is assessed with the Carney (2012) consensus sleep diary. This is measured in minutes (higher scores indicating longer sleep onset latency).

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  4. The change of wake after sleep onset from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    Wake after sleep onset is assessed with the Carney (2012) consensus sleep diary. This is measured in minutes (higher scores indicating longer wake after sleep onset).

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  5. The change of terminal wakefulness from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    Terminal wakefulness is assessed with the Carney (2012) consensus sleep diary. This is measured in minutes (higher scores indicating longer terminal wakefulness).

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  6. The change of sleep efficiency from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    Sleep efficiency is assessed with the Carney (2012) consensus sleep diary. This is measured in percentage (higher scores indicating better sleep efficiency).

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  7. The change of total sleep time from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    Total sleep time is assessed with the Carney (2012) consensus sleep diary. This is measured in minutes (higher scores indicating longer total sleep time).

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  8. The change of time in bed from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    Time in bed is assessed with the Carney (2012) consensus sleep diary. This is measured in minutes (higher scores indicating longer time in bed).

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  9. The change of Insomnia severity index (ISI) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    The ISI reporting insomnia symptoms severity consists of 7-items on a 5-point Likert scale, and the total score ranges from 0 to 28 with higher scores indicating more severe insomnia.

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  10. The change of Short Form 36 (SF-36) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    The SF-36 quantifing the quality of life in relation to health status consists of 36-items with eight areas covering physical functioning, role limitations brought on by physical issues, bodily pain, general health perceptions, vitality, social functioning, role limitations brought on by emotional issues, and perceived mental health. The total score ranges from 0-100 (the worst possible to the most possible).

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  11. The change of PHQ-15 total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    The PHQ-15 measuring somatic distress consists of 15 items, and the total score ranges from 0 to 30 with higher scores indicating more severe somatic distress.

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  12. The change of PDQ-D-5 total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    The PDQ-D-5 assessing perceived cognitive deficits from the patient's perspective consists of 5 items, and the total score ranges from 0 to 20 with higher scores indicating greater perceived deficit.

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  13. The change of SHAPS total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    The SHAPS assessing anhedonia consists of 14 items, and the total score ranges from 14 to 56 with higher scores indicating more serious the anhedonia.

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

  14. The change of Life Events Scale (LES) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.

    The LES assessing the perceived stress and number of stressful life events experienced consists of 48 items which are classified into three dimensions: family life events (28 items), work and study events (13 items), and social events (7 items) with higher scores in LES perceived greater stressfulness.

    Time frame: Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

07

Study locations

3 of 5 sites recruiting
  • Xuanwu Hospital, Capital Medical University
    Beijing, 100053, China
    Recruiting
  • Beijing Tiantan Hospital, Capital Medical University
    Beijing, 100070, China
    Recruiting
  • The First Bethune Hospital of Jilin University
    Changchun, China
    • Zan Wang, MD & PhD · Contact
    Not yet recruiting
  • West China Hospital, Sichuan University
    Chengdu, 610041, China
    Recruiting
  • The Second Affiliated Hospital of Soochow University
    Suzhou, China
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2022 (actual). Primary completion is estimated for Oct 2025, 34 months after the start.

Of 76 non-industry observational studies under Sleep Initiation and Maintenance Disorders, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 41. This study's planned 34 months is above that.

Counting every sponsor, half of 83 studies reached it within 22 months; a quarter within 6 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 1, 2024
First posted
Apr 19, 2024
StartActual
Dec 1, 2022
Primary completionEst.
Oct 31, 2025
CompletionEst.
Dec 31, 2025
Last update
Dec 10, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06375447
Collaborators
West China Hospital, Beijing Tiantan Hospital, Second Affiliated Hospital of Soochow University, Chifeng City Center Hospital Ningcheng County
Responsible party
Sponsor
First posted
Apr 19, 2024
Start date
Dec 1, 2022
Primary completion
Oct 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Dec 10, 2024

Study contacts

Huang Wang, MD
Contact
wanghuang1118@163.com
01083198513
Hongxing Wang, MD & PhD
study director · Xuanwu Hospital, Beijing

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion